Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoconazole With or Without Alendronate Sodium in Metastatic Prostate Cancer
NCT00019695Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Mar 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of alendronate in prostate cancer (PCa) (2 arms), sponsored by National Cancer Institute. Primary endpoint: Disease Response Rate. Started Mar 1999; status: terminated.
02
Drugs
alendronate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00019695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00019695.